Home/Filings/4/0001123292-20-000196
4//SEC Filing

Varghese Santosh T 4

Accession 0001123292-20-000196

CIK 0000881524other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 5:23 PM ET

Size

6.3 KB

Accession

0001123292-20-000196

Insider Transaction Report

Form 4
Period: 2020-01-29
Varghese Santosh T
VP, Medical & Reg Affairs
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-01-29+32,00032,000 total
    Exercise: $2.21Common Stock (32,000 underlying)
Footnotes (2)
  • [F1](i) One-half of the total number of shares subject to the stock option will vest and become exercisable over four years, such that one-fourth of such shares will vest and become exercisable on January 29, 2021 and an additional one forty-eighth of such shares will vest and become exercisable monthly thereafter over a period of three years following the first anniversary of the date of grant, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2018 Equity Incentive Plan) on the relevant vesting dates; and (ii) one-half of the total number of shares subject to the stock option will vest and become exercisable upon the achievement of both: (a) satisfaction of a performance target involving the Issuer's enterprise value and (b) the passage of at least two years from the date of grant, subject to the reporting person continuing to be a Service Provider upon the achievement of the later of (a) and (b).
  • [F2]The option expires on the earlier of (a) January 29, 2027 and (b) the twelve (12) month anniversary of the date the reporting person ceases to be a Service Provider (as defined in the Issuer's 2018 Equity Incentive Plan).

Issuer

VIVUS INC

CIK 0000881524

Entity typeother

Related Parties

1
  • filerCIK 0001640688

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:23 PM ET
Size
6.3 KB